Italy Drug Delivery Devices Market Growth & Forecast [2031]

Segments - Italy Drug Delivery Devices Market by Route of Applications (Cardiovascular, Diabetes, Infectious Diseases, Cancer, and Other), Administration (Topical, Ocular, Injectable, and Others), End Users (Hospitals, Ambulatory Surgical Centers, and Others) Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The Italy drug delivery devices market size is anticipated to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the Italy moving towards value-based healthcare and rising technological advancements, growth in the biologics market.

Italy Drug Delivery Devices Market Key Takeaways

People with chronic ailments like as arthritis, diabetes, and heart disease may one day be able to abandon their daily pharmaceutical routine in favor of a grape-sized implant that can be regulated remotely.

The increased incidence of chronic illnesses, technical improvements, and the expansion of the biologics industry are all projected to propel the drug delivery devices market forward throughout the forecast period.

In Italy lifespan is linked to Diet where unhealthy life style such as smoking, high BMI, alcohol consumption, and a lack of physical exercise are all variables that contribute to the Italian population's illness burden.

Italy growing elderly population noticing increase number of patients diagnosed with cardiovascular problems as upper age group are higher vulnerability of acquiring heart illnesses.

There has been a rising adoption and inclination toward enhanced medication delivery systems since they assist administer pharmaceuticals that are good for the targeted population to recover quicker. Furthermore, an increase in the number of malignancies, respiratory disorders, and diabetes patients throughout the world may encourage the use of medication delivery systems and boost the total market.

Diabetes mellitus affected around 3.5 million Italians in 2019. This represents an increase over 2010, when 2.9 million people were impacted by the condition. The number of instances was proportional to the patients' age. Diabetes was, in fact, far more frequent among the elderly than among the younger population. Diabetes mellitus harmed over one million persons aged 65 to 74 years and 1.4 million people aged 75 and more in Italy in 2019.

There have been huge advancements in the field of delivery systems recently, such as Nanomedicine and nano delivery systems, which are both relatively young yet quickly emerging sciences. Nanotechnology provides a number of advantages in the treatment of chronic human diseases by allowing precise medications to be delivered to specified locations.

Microneedles are a novel, effective method for delivering therapeutic drugs and immunobiological in a variety of disorders. These drug-loaded microneedles deliver medications deep into the skin, near neutrophils, langerhans, and dendritic cells, inducing the necessary immune response.

Because of the disadvantages of traditional cancer treatment, the attention has switched to the use of microneedles for not only anti-cancer vaccine/drug delivery but also early cancer diagnostics.

Another recently developed technology is transdermal drug delivery has recently progressed from crude approaches that depend only on natural diffusion to dynamic drug release systems that respond to external stimuli. Microneedles have also been used to break through physical barriers in the skin, allowing for regulated distribution via wearable biosensors.

Market Trends, Drivers, Restraints, and Opportunities

Development in new generation devices such as portable and wearable are gaining popularity particularly in the home healthcare market.
Rise in the incidence of cardiovascular illnesses (CVD), demanding the use of long-term medication.
Development of novel drug therapies is anticipated to fuel the market even further.
Increased awareness among population for drug are projected to boost the Italian drug delivery devices market.
Rising Obesity and diabetes among the urban population leading to heart related issue is the major driver for the market.
Early Preventive treatment, are gaining popularity such as remote monitoring, and early detection of at-risk individuals are fueling the market.
Italy government has enacted a number of European Union (EU) directives and rules relating to medical devices which can be a restrain for the exporter companies.
Research and development in novel drugs and delivery system are creating a significant opportunity for market player.

Scope of the Report

The report on Italy drug delivery devices Market the includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Drug Delivery Devices Market - Italy Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Route of Applications (Cardiovascular, Diabetes, Infectious Diseases, Cancer, and Other), Administration (Topical, Ocular, Injectable, and Others), End Users (Hospitals, Ambulatory Surgical Centers, and Others)
Country Scope	Italy
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Biocorp; Becton; Dickinson and Company; West Pharmaceutical Services Inc; Elcam Medical; Antares Pharma Inc.

Italy Drug Delivery Devices Market Segment Insights

The cardiovascular segment is estimated to account for a major market share

Based on route of applications, Italy drug delivery devices market is divided into cardiovascular, diabetes, infectious diseases, cancer, and other. The cardiovascular is expected to represent a key share of the market due to the aging population and behavioral changes in lifestyles, lead to long-term heart problems.

Italy Drug Delivery Devices Market By Applications

The injectable segment is expected to grow at a robust pace

In terms of administration, the Italy drug delivery devices market is segmented into topical, ocular, injectable, and others. The injectable segment is expected to represent a key share of the market in the coming years due to research advancement such as microneedle and also effective drug delivery.

The hospitals segment is anticipated to register rapid CAGR

On the basis of end users, the Italy drug delivery devices market is divided into hospitals, ambulatory surgical centers, and other. The hospitals segment is expected to constitute a key share of the market during the forecast period due to increased elderly population and advancements in pharmaceutical or drug delivery technologies.

Segments

The Italy drug delivery devices market has been segmented on the basis of

Applications

Cardiovascular
Diabetes
Infectious Diseases
Cancer
Other

Administration

Topical
Ocular
Injectable
Others

End User

Hospitals
Ambulatory Surgical Centers
Others

Country

Italy

Key Players

Biocorp
Becton
Dickinson and Company
West Pharmaceutical Services Inc
Elcam Medical
Antares Pharma Inc

Competitive Landscape

Key players competing in the Italy drug delivery devices market include Biocorp; Becton; Dickinson and Company; West Pharmaceutical Services Inc; Elcam Medical; Antares Pharma Inc.

Some of these players are focusing on business strategies including partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Italy Drug Delivery Devices Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Drug Delivery Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Drug Delivery Devices Market - Supply Chain
  4.5. Global Drug Delivery Devices Market Forecast
     4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Drug Delivery Devices Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Drug Delivery Devices Market Size and Volume Forecast by Applications
     5.3.1. Cardiovascular Diabetes Infectious Diseases Cancer Other
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Drug Delivery Devices Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Drug Delivery Devices Market Size and Volume Forecast by End Users
     6.3.1. Hospitals Ambulatory Surgical Centers Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Drug Delivery Devices Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Drug Delivery Devices Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
8. North America Drug Delivery Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Drug Delivery Devices Market Size and Volume Forecast by Applications
     8.4.1. Cardiovascular Diabetes Infectious Diseases Cancer Other
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Drug Delivery Devices Market Size and Volume Forecast by End Users
     8.7.1. Hospitals Ambulatory Surgical Centers Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Latin America Drug Delivery Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Drug Delivery Devices Market Size and Volume Forecast by Applications
     9.4.1. Cardiovascular Diabetes Infectious Diseases Cancer Other
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Drug Delivery Devices Market Size and Volume Forecast by End Users
     9.7.1. Hospitals Ambulatory Surgical Centers Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Europe Drug Delivery Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Drug Delivery Devices Market Size and Volume Forecast by Applications
     10.4.1. Cardiovascular Diabetes Infectious Diseases Cancer Other
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Drug Delivery Devices Market Size and Volume Forecast by End Users
     10.7.1. Hospitals Ambulatory Surgical Centers Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Applications
     11.4.1. Cardiovascular Diabetes Infectious Diseases Cancer Other
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by End Users
     11.7.1. Hospitals Ambulatory Surgical Centers Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
12. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Applications
     12.4.1. Cardiovascular Diabetes Infectious Diseases Cancer Other
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by End Users
     12.7.1. Hospitals Ambulatory Surgical Centers Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Drug Delivery Devices Market: Market Share Analysis
  13.2. Drug Delivery Devices Distributors and Customers
  13.3. Drug Delivery Devices Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Biocorp Becton Dickinson and Company West Pharmaceutical Services Inc Elcam Medical Antares Pharma Inc